ReShape Lifesciences has signed a distribution agreement with Liaison Medical for distribution of ReShape’s next generation, enhanced Lap-Band 2.0 FLEX and Tubing Kit, in Canada.
“The signing of this distribution agreement in Canada, on the heels of the November 2024 approval by Health Canada for the Lap-Band 2.0 FLEX, is a testament to our commitment to broadly launching this important product to improve the patient experience,” stated Paul F Hickey, President and Chief Executive Officer of ReShape Lifesciences. “Initial surgeon feedback from our limited market release of the Lap-Band 2.0 FLEX in the US was overwhelmingly positive. The new FLEX technology, which acts as a relief valve to alleviate discomfort from swallowing large pieces of food, can eliminate the need for in-office band adjustments as the band momentarily relaxes before returning to its resting diameter. We look forward to working closely with Liaison Medical on the launch of the Lap-Band 2.0 FLEX in Canada which we believe, over time, will meaningfully add to the sales of the Lap-Band franchise.”
“We are excited to partner with ReShape Lifesciences and add the Lap-Band 2.0 FLEX to our portfolio of innovative surgical devices,” added Denis Langevin, President and Chief Executive Officer of Liaison Medical. “Based on our extensive experience and deep relationships with hospitals, we have become one of the largest surgical device distributors in Canada. As a result, we already know the bariatric surgeons and believe, based on the improved features of the Lap-Band 2.0 FLEX, that this device will be a growth catalyst for the company.”
Comments